| |
|
Philippines: One year after drug price control
|
|
Published on :
Thursday, August 19, 2010 |
|
On August 15th 2010 the drug price control or price regulation policy will turn exactly 1-year-old. The policy has not achieved its goal of making essential, popular and branded drugs become more accessible to the poor. Price control was not a success in making more popular, previously expensive drugs by multinational pharma companies become more affordable to the poor, writes BIENVENIDO OPLAS JR. in the Manila Times.
|
|
|
|
|
Pune: Doctor sells H1N1 vaccine for Rs 1400, ten times the actual pricec
|
|
Published on :
Friday, August 13, 2010 |
|
A pune doctor sells H1N1 vaccines for Rs. 1400 a shot. It is nearly ten times the original price of the H1N1 vaccine.The actual cost of the vaccine is Rs. 150 per dose. The doctor defended himself by saying that she had taken the risk of testing the vaccine on herself and even argued that giving six doses from a five-dose vial was all right, reports NDTV.
|
|
|
|
|
Five-in-one vaccine led to child deaths: experts
|
|
Published on :
Thursday, July 29, 2010 |
|
Experts say that five-in-one vaccine recommended India by the National Technical Advisory Group on Immunization led to chhild deaths in Sri lanka and Bhutan. Five-in-one vaccine combines antigens against diphtheria, pertussis, tetanus (DPT), hepatitis B and Haemophilus Influenzae type B (HIB) - in a single shot, reports Sify News. |
|
|
|
|
H1N1 nasal vaccine popular with patients
|
|
Published on :
Wednesday, July 28, 2010 |
|
Nosavac, the H1N1 nasal vaccine is enormously popular with patients. Nosavac is India's first nasal vaccine against swine flu. The vaccine has a short shelf life of nune months, reports Hindustan Times |
|
|
|
|
Antibiotics could act as 'needle free' malaria vaccine
|
|
Published on :
Wednesday, July 21, 2010 |
|
A new study found that advance administration of antiobiotics in malaria ridden areas can act as a natural 'needle free' vaccine against the disease. The measure was tested on mice successfully, reports The Hindu. |
|
|
|
|
A universal vaccine against every type of flu
|
|
Published on :
Friday, July 16, 2010 |
|
A new vaccine which would prevent all types of flu and in the making by an internation team. It is likely to be available in a few years, probably as early as 2013.The vaccine was tested positively on mice, ferrets and monkeys/Experts have backed the research, reports The Hindu. |
|
|
|
|
India's own nasal vaccine for H1N1 priced at Rs 160 per shot
|
|
Published on :
Thursday, July 15, 2010 |
|
The first indigenous intra-nasal vaccine was launched in Mumbai on wednesday.It will guard people against H1N1 virus for a year or two.Around 1000 people died of swine flu in the last one year. The vaccine is the result of hard work of Indian scientists for a long time, reports The Times of India. |
|
|
|
|
H1N1 virus provides clues to universal flu vaccine
|
|
Published on :
Thursday, July 15, 2010 |
|
The creation of a universal flu vaccine which is likely to provide immunity against several strains might be helped by an H1N1 virus.By latching on to the hemagglutinin protein, the antibodies prevent the virus from infecting cells and reproducing itself inside them, reports The Hindu. |
|
|
|
|
U.S. scientists create HIV resistant cells
|
|
Published on :
Saturday, July 03, 2010 |
|
HIV-resistant cells which will control the virus were created by American scientists. The cells target molecules which allow HIV to enter human cells. The scientists have applied it on mouses successfully,reports The Hindu. |
|
|
|
|
Novo Nordisk launches diabetes drug
|
|
Published on :
Monday, June 07, 2010 |
|
Victoza, a drug designed to treat type 2 diabetes was launched by the leading healthcare company Novo Nordisk on Monday. The disease is caused by insulin, used or made in a wrong manner by the body. Victoza would control blood sugar, reports The Hindu.
|
|
|
|
|